Insider Transactions in Q3 2024 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2024
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.72%
|
$140,000
$14.0 P/Share
|
|
Sep 18
2024
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.92%
|
$10,000
$1.5 P/Share
|
|
Sep 17
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,200,000
$12.93 P/Share
|
|
Sep 17
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,200,000
$12.93 P/Share
|
|
Sep 10
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,100,000
$11.5 P/Share
|
|
Sep 10
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,100,000
$11.5 P/Share
|
|
Aug 26
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
83,695
-100.0%
|
$1,088,035
$13.0 P/Share
|
|
Aug 26
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
83,695
-100.0%
|
$1,088,035
$13.0 P/Share
|
|
Aug 23
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
69,500
-45.37%
|
$903,500
$13.03 P/Share
|
|
Aug 23
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
69,500
-45.37%
|
$903,500
$13.03 P/Share
|
|
Aug 22
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
391,482
-71.87%
|
$4,697,784
$12.94 P/Share
|
|
Aug 22
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
391,482
-71.87%
|
$4,697,784
$12.94 P/Share
|
|
Aug 21
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
407,700
-21.9%
|
$5,707,800
$14.07 P/Share
|
|
Aug 21
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
407,700
-21.9%
|
$5,707,800
$14.07 P/Share
|
|
Aug 20
2024
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-48.64%
|
$200,000
$16.0 P/Share
|
|
Aug 20
2024
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+32.72%
|
$12,500
$1.5 P/Share
|
|
Aug 20
2024
|
Brian Dorsey Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-89.25%
|
$750,000
$15.0 P/Share
|
|
Aug 20
2024
|
Brian Dorsey Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+47.16%
|
$0
$0.64 P/Share
|
|
Aug 20
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.08%
|
$1,500,000
$15.54 P/Share
|
|
Aug 20
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-1.08%
|
$1,500,000
$15.54 P/Share
|
|
Aug 19
2024
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.72%
|
$140,000
$14.0 P/Share
|
|
Aug 19
2024
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.92%
|
$10,000
$1.5 P/Share
|
|
Aug 13
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.63%
|
$1,200,000
$12.27 P/Share
|
|
Aug 13
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-1.63%
|
$1,200,000
$12.27 P/Share
|
|
Aug 13
2024
|
Brian Dorsey Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-83.28%
|
$390,000
$13.0 P/Share
|
|
Aug 13
2024
|
Brian Dorsey Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+45.44%
|
$0
$0.64 P/Share
|
|
Jul 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.08%
|
$1,100,000
$11.4 P/Share
|
|
Jul 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.08%
|
$1,100,000
$11.4 P/Share
|
|
Jul 09
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.09%
|
$900,000
$9.62 P/Share
|
|
Jul 09
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.09%
|
$900,000
$9.62 P/Share
|